Limits...
Mutant p63 causes defective expansion of ectodermal progenitor cells and impaired FGF signalling in AEC syndrome.

Ferone G, Thomason HA, Antonini D, De Rosa L, Hu B, Gemei M, Zhou H, Ambrosio R, Rice DP, Acampora D, van Bokhoven H, Del Vecchio L, Koster MI, Tadini G, Spencer-Dene B, Dixon M, Dixon J, Missero C - EMBO Mol Med (2012)

Bottom Line: The AEC mutation exerts a selective dominant-negative function on wild-type p63 by affecting progenitor cell expansion during ectodermal development leading to a defective epidermal stem cell compartment.These phenotypes are associated with impairment of fibroblast growth factor (FGF) signalling resulting from reduced expression of Fgfr2 and Fgfr3, direct p63 target genes.Restoring Fgfr2b expression in p63(+/L514F) epithelial cells by treatment with FGF7 reactivates downstream mitogen-activated protein kinase signalling and cell proliferation.

View Article: PubMed Central - PubMed

Affiliation: Fondazione IRCCS SDN, Napoli, Italy.

Show MeSH

Related in: MedlinePlus

Rescue of FGF signalling by exogenous Fgfr2b expression in mutant epidermal cellsImmunoblotting analysis for Fgfr2, Fgfr3 and the phosphorylated active form of the downstream signalling proteins FRS2α (p-FRS2α) and ERK (p-ERK) reveals downregulation of the FGF receptor and downstream signalling in p63+/L514F keratinocytes compared to controls. Tubulin was used to normalize samples for protein content.Immunoblotting analysis for ERK phosphorylation reveals reduced ERK activation in p63+/L514F starved keratinocytes compared to controls upon KGF treatment. Exogenous expression of Fgfr2b and concomitant treatment with KGF can restore ERK phosphorylation. Total ERK protein levels were used as control. pFRS2α was used as control of FGFR activation.BrdU incorporation of starved keratinocytes treated as in (B) reveals that p63+/L514F cells have a defective cell proliferation in the absence of exogenous growth factors. Rescue is obtained by exogenous expression of Fgfr2b and concomitant treatment with KGF (25% difference between mock-infected untreated samples and KGF treated/Fgfr2b expressing cells; p-value = 0.005, n = 6 of three independent experiment). Data are represented as mean ± SD.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3376849&req=5

fig05: Rescue of FGF signalling by exogenous Fgfr2b expression in mutant epidermal cellsImmunoblotting analysis for Fgfr2, Fgfr3 and the phosphorylated active form of the downstream signalling proteins FRS2α (p-FRS2α) and ERK (p-ERK) reveals downregulation of the FGF receptor and downstream signalling in p63+/L514F keratinocytes compared to controls. Tubulin was used to normalize samples for protein content.Immunoblotting analysis for ERK phosphorylation reveals reduced ERK activation in p63+/L514F starved keratinocytes compared to controls upon KGF treatment. Exogenous expression of Fgfr2b and concomitant treatment with KGF can restore ERK phosphorylation. Total ERK protein levels were used as control. pFRS2α was used as control of FGFR activation.BrdU incorporation of starved keratinocytes treated as in (B) reveals that p63+/L514F cells have a defective cell proliferation in the absence of exogenous growth factors. Rescue is obtained by exogenous expression of Fgfr2b and concomitant treatment with KGF (25% difference between mock-infected untreated samples and KGF treated/Fgfr2b expressing cells; p-value = 0.005, n = 6 of three independent experiment). Data are represented as mean ± SD.

Mentions: To determine the contribution of Fgfr2b and Fgfr3b downregulation to FGF signalling and cell proliferation, we measured the levels of FGFR substrate 2α (FRS2α) tyrosine phosphorylation. In p63+/L514F primary keratinocytes, a strong reduction of Fgfr2b and Fgfr3b proteins was accompanied with a significant decrease in FRS2α phosphorylation (Fig 5A) indicating impaired activation of FGF signalling. FGF signalling leads to induction of the classical Ras/extracellular signal regulated kinase (ERK) pathway. In spite of impaired FGF receptor activity, ERK phosphorylation was unaffected in p63+/L514F keratinocytes. The presence of several other growth factors in the fully supplemented medium in which cells were grown may compensate for the impaired FGF receptor activity. In contrast, treatment of starved wild-type cells with KGF (keratinocyte growth factor or FGF-7), the Fgfr2b-specific ligand, resulted in ERK phosphorylation, whereas in mutant keratinocytes, ERK phosphorylation was impaired (Fig 5B). Restoring Fgfr2b expression by retroviral Fgfr2b transfer rescued ERK activation upon KGF treatment. As expected, EGF treatment elicited a similar induction in ERK phosphorylation in both wild-type and mutant keratinocytes, and exogenous Fgfr2b expression had no effect on EGF-induced ERK phosphorylation (Supporting Information Fig S9A) indicating a specific impairment of FGF/Ras/ERK pathway activation in mutant cells.


Mutant p63 causes defective expansion of ectodermal progenitor cells and impaired FGF signalling in AEC syndrome.

Ferone G, Thomason HA, Antonini D, De Rosa L, Hu B, Gemei M, Zhou H, Ambrosio R, Rice DP, Acampora D, van Bokhoven H, Del Vecchio L, Koster MI, Tadini G, Spencer-Dene B, Dixon M, Dixon J, Missero C - EMBO Mol Med (2012)

Rescue of FGF signalling by exogenous Fgfr2b expression in mutant epidermal cellsImmunoblotting analysis for Fgfr2, Fgfr3 and the phosphorylated active form of the downstream signalling proteins FRS2α (p-FRS2α) and ERK (p-ERK) reveals downregulation of the FGF receptor and downstream signalling in p63+/L514F keratinocytes compared to controls. Tubulin was used to normalize samples for protein content.Immunoblotting analysis for ERK phosphorylation reveals reduced ERK activation in p63+/L514F starved keratinocytes compared to controls upon KGF treatment. Exogenous expression of Fgfr2b and concomitant treatment with KGF can restore ERK phosphorylation. Total ERK protein levels were used as control. pFRS2α was used as control of FGFR activation.BrdU incorporation of starved keratinocytes treated as in (B) reveals that p63+/L514F cells have a defective cell proliferation in the absence of exogenous growth factors. Rescue is obtained by exogenous expression of Fgfr2b and concomitant treatment with KGF (25% difference between mock-infected untreated samples and KGF treated/Fgfr2b expressing cells; p-value = 0.005, n = 6 of three independent experiment). Data are represented as mean ± SD.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3376849&req=5

fig05: Rescue of FGF signalling by exogenous Fgfr2b expression in mutant epidermal cellsImmunoblotting analysis for Fgfr2, Fgfr3 and the phosphorylated active form of the downstream signalling proteins FRS2α (p-FRS2α) and ERK (p-ERK) reveals downregulation of the FGF receptor and downstream signalling in p63+/L514F keratinocytes compared to controls. Tubulin was used to normalize samples for protein content.Immunoblotting analysis for ERK phosphorylation reveals reduced ERK activation in p63+/L514F starved keratinocytes compared to controls upon KGF treatment. Exogenous expression of Fgfr2b and concomitant treatment with KGF can restore ERK phosphorylation. Total ERK protein levels were used as control. pFRS2α was used as control of FGFR activation.BrdU incorporation of starved keratinocytes treated as in (B) reveals that p63+/L514F cells have a defective cell proliferation in the absence of exogenous growth factors. Rescue is obtained by exogenous expression of Fgfr2b and concomitant treatment with KGF (25% difference between mock-infected untreated samples and KGF treated/Fgfr2b expressing cells; p-value = 0.005, n = 6 of three independent experiment). Data are represented as mean ± SD.
Mentions: To determine the contribution of Fgfr2b and Fgfr3b downregulation to FGF signalling and cell proliferation, we measured the levels of FGFR substrate 2α (FRS2α) tyrosine phosphorylation. In p63+/L514F primary keratinocytes, a strong reduction of Fgfr2b and Fgfr3b proteins was accompanied with a significant decrease in FRS2α phosphorylation (Fig 5A) indicating impaired activation of FGF signalling. FGF signalling leads to induction of the classical Ras/extracellular signal regulated kinase (ERK) pathway. In spite of impaired FGF receptor activity, ERK phosphorylation was unaffected in p63+/L514F keratinocytes. The presence of several other growth factors in the fully supplemented medium in which cells were grown may compensate for the impaired FGF receptor activity. In contrast, treatment of starved wild-type cells with KGF (keratinocyte growth factor or FGF-7), the Fgfr2b-specific ligand, resulted in ERK phosphorylation, whereas in mutant keratinocytes, ERK phosphorylation was impaired (Fig 5B). Restoring Fgfr2b expression by retroviral Fgfr2b transfer rescued ERK activation upon KGF treatment. As expected, EGF treatment elicited a similar induction in ERK phosphorylation in both wild-type and mutant keratinocytes, and exogenous Fgfr2b expression had no effect on EGF-induced ERK phosphorylation (Supporting Information Fig S9A) indicating a specific impairment of FGF/Ras/ERK pathway activation in mutant cells.

Bottom Line: The AEC mutation exerts a selective dominant-negative function on wild-type p63 by affecting progenitor cell expansion during ectodermal development leading to a defective epidermal stem cell compartment.These phenotypes are associated with impairment of fibroblast growth factor (FGF) signalling resulting from reduced expression of Fgfr2 and Fgfr3, direct p63 target genes.Restoring Fgfr2b expression in p63(+/L514F) epithelial cells by treatment with FGF7 reactivates downstream mitogen-activated protein kinase signalling and cell proliferation.

View Article: PubMed Central - PubMed

Affiliation: Fondazione IRCCS SDN, Napoli, Italy.

Show MeSH
Related in: MedlinePlus